Division of Cardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
Division of Cardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
Ann Thorac Surg. 2014 Jul;98(1):232-5; discussion 235-7. doi: 10.1016/j.athoracsur.2014.03.003. Epub 2014 May 6.
Our objective was to determine the incidence and optimal management of chylothorax after pulmonary resection with complete thoracic mediastinal lymph node dissection (MLND).
This is a retrospective review of patients who underwent pulmonary resection with MLND.
Between January 2000 and December 2012, 2,838 patients underwent pulmonary resection with MLND by one surgeon (RJC). Forty-one (1.4%) of these patients experienced a chylothorax. Univariate analysis showed that lobectomy (p<0.001), a robotic approach (p=0.03), right-sided operations (p<0.001), and pathologic N2 disease (p=0.007) were significantly associated with the development of chylothorax. Multivariate analysis showed that lobectomy (p=0.011), a robotic approach (p=0.032), and pathologic N2 disease (p=0.027) remained predictors. All patients were initially treated with cessation of oral intake and 200 μg subcutaneous somatostatin every 8 hours. If after 48 hours the chest tube output was less than 450 mL/day and the effluent was clear, patients was given a medium-chain triglyceride (MCT) diet and were observed for 48 hours in the hospital. If the chest tube output remained below 450 mL/day, the chest tube was removed, they were discharged home with directions to continue the MCT diet and to return in 2 weeks. Patients were instructed to consume a high-fat meal 24 hours before their clinic appointment. If the patient's chest roentgenogram was clear at that time, they were considered "treated." This approach was successful in 37 (90%) patients. The 4 patients in whom the initial treatment was unsuccessful underwent reoperation with pleurodesis and duct ligation.
Chylothorax after pulmonary resection and MLND occurred in 1.4% of patients. Its incidence was higher in those with pathologic N2 disease and those who underwent robotic resection. Nonoperative therapy is almost always effective.
我们的目的是确定在完全性纵隔淋巴结清扫(MLND)后肺切除术后乳糜胸的发生率和最佳处理方法。
这是对接受 MLND 肺切除术的患者进行的回顾性研究。
2000 年 1 月至 2012 年 12 月,一位外科医生(RJC)对 2838 例患者行肺切除术和 MLND。其中 41 例(1.4%)发生乳糜胸。单因素分析显示,肺叶切除术(p<0.001)、机器人手术(p=0.03)、右侧手术(p<0.001)和病理性 N2 疾病(p=0.007)与乳糜胸的发生显著相关。多因素分析显示,肺叶切除术(p=0.011)、机器人手术(p=0.032)和病理性 N2 疾病(p=0.027)仍然是预测因素。所有患者最初均接受停止口服摄入和 200μg 皮下生长抑素,每 8 小时一次。如果 48 小时后胸腔引流管引流量少于 450mL/天且流出物清澈,患者给予中链甘油三酯(MCT)饮食,并在医院观察 48 小时。如果胸腔引流管引流量仍低于 450mL/天,则拔除胸腔引流管,患者出院回家,继续给予 MCT 饮食,并在 2 周后复诊。患者被指示在就诊前 24 小时进食高脂肪餐。如果此时患者的胸部 X 光片清晰,则认为“已治疗”。这种方法在 37 例(90%)患者中取得成功。4 例初始治疗无效的患者接受了胸膜固定术和导管结扎术的再次手术。
肺切除和 MLND 后乳糜胸的发生率为 1.4%。在病理性 N2 疾病和接受机器人手术的患者中,其发生率更高。非手术治疗几乎总是有效的。